The purpose of this study is to assess the effect of food on the drug levels of Admilparant

Inclusion Criteria

• Participants must have a body mass index (BMI) of 18.0 kg/m2 to 32.0 kg/m2, inclusive, at screening.
• Participants must have a body weight of ≥ 50 kg for males and ≥ 45 kg for females at screening.

Exclusion Criteria

• Participants must not have any significant medical condition, laboratory abnormality, or psychiatric illness that would prevent the participant from participating in the study.
• Participants must not have had any previous exposure to Admilparant.
• Participants must not have a history of any severe drug allergy or drug reaction (such as anaphylaxis or hepatotoxicity).
• Other protocol-defined Inclusion/Exclusion criteria apply.

BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at: https://www.bms.com/researchers-and-partners/clinical-trials-and-research/disclosure-commitment.html

See plan description

See plan description